Ai For Health[4]

Onsite Event Participants

Carlotta Altringer

VitrofluidiX (Germany)

Drug discovery

Celia Antonio Schell

MultiOmic Health Limited (United Kingdom)

Drug discovery

prevention

Jonathan Apasu

Adon Health (Germany)

Virtual care

prevention

Alex Apelbaum

AA Global Consulting (Switzerland)

Lina Baamer

GP Bullhound Ltd (United Kingdom)

Fabricia Beltramini

Senior Manager Digitalisation & Innovation
TÜV NORD GROUP (Germany)

Michela Beretta

COI&C Resources & Events Coordinator
Chiesi Farmaceutici (Italy)

Matteo Berlucchi

CEO
Healthily (formerly Your.MD) (United Kingdom)

Gunjan Bhardwaj

Partex NV (Germany)

Sandra Bobersky

ZKIMED - Center for AI, Medical Informatics, and Data Science (Germany)

prevention

Bartosz Borucki

Smarter Diagnostics (Poland)

prevention

Paulus Carpelan

Adamant Health oy (Finland)

Virtual care

prevention

Pedro Castel-Branco

Armilar Venture Partners (Portugal)

Virtual care

Drug discovery

prevention

Mathieu Chaffard

Roche Diagnostics International (Switzerland)

Virtual care

Drug discovery

prevention

Fabrizio Conicella

head Open Innovation & Competence
Chiesi Farmaceutici (Italy)

Virtual care

Antoine D'Hollander

Investment Manager
Capricorn Partners (Belgium)

Virtual care

prevention

Vasilios Danos

Head of AI Security & Trustworthiness
TÜV Informationstechnik GmbH - TÜVIT (Germany)

Sune Darkner

DARERL ApS (Denmark)

Virtual care

prevention

Soumya Dash

Sleepiz AG (Switzerland)

Virtual care

Drug discovery

prevention

Coenraad Davidsdochter

Senior Consultant
Qserve Group (Netherlands)

Virtual care

prevention

Vasilis Dimakopoulos

Aisthesis Medical (United Kingdom)

Virtual care

prevention

Blagovesta Dlagatseva

Investors Club Manager & Business Development
Tech Tour (Bulgaria)

Jana Drechsler

Project Management Healthcare
EWG - Essener Wirtschaftsförderung (Germany)

Virtual care

Omar El Nahhas

StratifAI (Germany)

Virtual care

Drug discovery

prevention

Jan Engels

Investment Manager
High-Tech Gruenderfonds (HTGF) (Germany)

Virtual care

Drug discovery

prevention

Roberta Ferrari

Managing Director
EQT Life Sciences (Netherlands)

Tanja Frankewitz

Head of auditservices medical devices western europe
TÜV NORD CERT (Germany)

Michael Friebe

Founding Partner
5P FUTURE OF HEALTH (Germany)

Haruka Fujita

Teijin Holdings Europe B.V. (Netherlands)

Larissa Gajewski

Startup Program Managerin
BRYCK (Germany)

Eva Garcia Ramos

e-HEALTH TECHNICAL SOLUTIONS SL (Spain)

Virtual care

Annalisa Gardella

Team Leader
Tech Tour Europe (Belgium)

Jan-Eric Gawande

aalto health GmbH (Germany)

Virtual care

prevention

Bart Geerts

Healthplus.ai (Netherlands)

Virtual care

prevention

Nedelcho Georgiev

Columbo (Bulgaria)

Virtual care

prevention

Maria Georgieva

Project Manager Healthtech
Tech Tour (Bulgaria)

Klaus Gerwert

CEO
betaSENSE (Germany)

Ioannis Gkouzionis

Aisthesis Medical (United Kingdom)

Virtual care

prevention

Markus Gratzfeld

Head of Auditservices Medical Devices International
TÜV NORD CERT (Germany)

Jan Gräfe

Managing Director
Gründerfonds Ruhr (Germany)

Virtual care

prevention

Nicolas Guggenheim

Independent Board Member and Strategic Investor in Healthcare
- (Switzerland)

Virtual care

Vishal Gulati

Managing Partner
Recode Health Ventures (United States)

Noushin Hadadi

Novigenix SA (Switzerland)

Drug discovery

prevention

Brian Hashemi

Partner
Salus Partners (Switzerland)

Tyler Hayes

Principal
Thuja Capital (Netherlands)

Drug discovery

prevention

Claas Heise

Executive Director
NRW Bank (Germany)

Virtual care

Drug discovery

Jannis Heuner

Managing Director
ruhrHUB (Germany)

Drug discovery

Jörg Holstein

Managing Partner
Meerkat Holding (Germany)

Mario Huyghe

Senior Venture Development Manager
imec (Belgium)

Virtual care

Drug discovery

Juho Immonen

Data Scientist
Bayer (Germany)

Drug discovery

prevention

Torsten Heerdegen Jepsen

CEO & CO-FOUNDER
Aiomic (Denmark)

prevention

Georgi Kadrev

Kelvin Health (Bulgaria)

prevention

Alper Karagoz

Partner
Diffusion Capital Partners (DCP) (Turkiye)

prevention

Jörg Kemna

CEO
Business Metropole Ruhr GmbH (Germany)

Dan Kirkland

Board Member
Sheffield Chamber of Commerce (United Kingdom)

Virtual care

Bernard Kirsch

Angels Santé (France, Metropolitan)

prevention

Angelika Klimaszewski

Startup-Beratung
Bochum Wirtschaftsentwicklung (Germany)

Nihat Koc

Venture Manager
Spotlight! Ventures (Germany)

Virtual care

Philipp Kopp

Investment Manager
bmp Ventures (Germany)

Drug discovery

Kai Krumbein

ruhrHUB (Germany)

Lauri Kuronen

CEO, Denmark unit
LKP-Invest (Finland)

Virtual care

Marc Kämmerer

VISUS Health IT (Germany)

Philippa Köhnk

BRYCK (Germany)

prevention

Nicolas Lagreze

Head of Venture Building
Fusion Partners (Switzerland)

Virtual care

prevention

Axel Lange

General Manager Sales & Marketing
TÜV Informationstechnik GmbH - TÜVIT (Germany)

Maarten Larmuseau

Nuclivision (Belgium)

Virtual care

Drug discovery

Robert Lauritzen

Cerebriu (Denmark)

Daniel Leite

AI4MedImaging - Medical Solutions S.A. (Portugal)

prevention

Steven Leuridan

Partner
Qbic (Belgium)

Virtual care

Drug discovery

prevention

Anastasia Liapis

Global Head of Strategy & Partnerships
HP Health Solutions (Germany)

Dirk Link

Projektmanager / Initiator
KAIROS - an IQVIA business (Germany)

Alex Loleyt

Traverse Health (Netherlands)

Drug discovery

Kirill Lopatin

xAID (Spain)

Virtual care

Drug discovery

Friedrich Lämmel

Thryve (Germany)

Virtual care

prevention

Thora Markert

Head of AI Research and Governance
TÜV Informationstechnik GmbH - TÜVIT (Germany)

Sebastian Merkel

Junior Professorship for Health and E-Health
Digi Health Start (Germany)

Karsten Miermans

hema.to (Germany)

Virtual care

Drug discovery

Marco Mohwinckel

Tech Tour Advisor
Magnolia Health Advisors (United Kingdom)

Virtual care

prevention

Christoph Monfeld

Quhr - Smart Health Hub Ruhr GmbH (Germany)

Virtual care

prevention

Hermann Monstadt

Vice President Corporate Innovation & Strategy
WallabyPhenox (Germany)

Virtual care

Czuee Morey

Xena Dx (Germany)

Virtual care

Antonio Murta

Managing Director
Pathena (Portugal)

prevention

Samuel Müller

ATLAS medical technology GmbH (Germany)

Virtual care

Peter Naeve

Digi Health Start (Germany)

Peter Nestorov

Scailyte AG (Switzerland)

Drug discovery

prevention

Niklas Obermann

Project coordinator HUMAINE
RUHR-UNIVERSITÄT BOCHUM (Germany)

Nicolas Olberg

IT Investor & Managing Director
Twip Impact Ventures (Germany)

Virtual care

Manuel Opitz

deepeye Medical GmbH (Germany)

Virtual care

Andreas Ostendorf

Head of Chair
Ruhr Universitaet Bochum LAT (Germany)

Xavier Pardo

Managing Director
Xerpa (Switzerland)

prevention

Juan Carlos Ondategui Parra

Co-Founder
e-HEALTH TECHNICAL SOLUTIONS SL (Spain)

Virtual care

prevention

Martin Paul

Rector
Ruhr Universitaet Bochum LAT (Germany)

Giuseppina Pavesi

Expert
down2business (Italy)

Tuomo Pentikäinen

CEO
Veil.ai (Finland)

Virtual care

Johannes Peuling

Head of Agency HealthCampus Bochum
Bochum Wirtschaftsentwicklung (Germany)

Virtual care

Kustaa Piha

CEO and Investor in Healthcare and Medtech
Athensmed Oy (Finland)

Virtual care

prevention

Steffen Preuß

icho systems (Germany)

prevention

Stefan Raue

Nooku (United Kingdom)

prevention

Maurice Reinhard

Investment Associate
Gründerfonds Ruhr (Germany)

Virtual care

prevention

Ellen Rettig

Product Manager at Institute for Vehicle Technology and Mobility (IFM)
TÜV NORD GROUP (Germany)

Thomas Roth

Inzipio GmbH (Germany)

Virtual care

prevention

Mar Rus-Calafell

The German Center for Mental Health (Germany)

Dietmar Schlößer

Director Digitalization & Innovation
TÜV NORD GROUP (Germany)

Virtual care

prevention

Jacco Schutte

Autoscriber (Netherlands)

Virtual care

Mehrdad Seirafi

Alpha Brain Technologies (Netherlands)

Virtual care

Maria Severina

CEO, Angel Investor
Almaral (Finland)

Virtual care

prevention

Lauri Sippola

Gosta Labs (Finland)

Virtual care

Philippe Skender

Project Manager, IT security innovation
Bochum Wirtschaftsentwicklung (Germany)

Marc Sommer

spexa GmbH (Germany)

prevention

Remi Spagnol

Investments Healthcare
Supernova Invest (France)

Virtual care

Drug discovery

prevention

Natalie Sporrer

Elixion Medical (Germany)

Virtual care

Madhur Srivastava

DocHQ Ltd (United Kingdom)

Virtual care

Christian Stephan

Managing Director
KAIROS - an IQVIA business (Germany)

prevention

William Stevens

Group Managing Director
Tech Tour Europe (Belgium)

Florian Stinauer

NRW.BANK (Germany)

Klaus Stoeckemann

Managing Partner & Co-Founder
Peppermint Venture Partners (Germany)

prevention

Christoph Sutter

Leiter Business Entity IT
TÜV NORD CERT (Germany)

Philip Taillieu

Cascador health (Belgium)

Drug discovery

Jukka Tapaninen

Aiforia Technologies Plc (Finland)

Drug discovery

prevention

Robert Thong

Chief Executive Officer
MultiOmic Health Limited (United Kingdom)

Drug discovery

Benno Tieke

Philips Ventures (Netherlands)

Jan Treffon

Bochumer Institut für Technologie gGmbH (Germany)

Virtual care

Drug discovery

prevention

Corina Turner

Smart In Media AG (Germany)

Virtual care

Drug discovery

prevention

Anna Maria Ullmann

Yeda (former YoniCore) by CoreCreation UG (Germany)

Virtual care

prevention

Ralph BMH van Aken

CEO & Owner
Wolf Nose (Netherlands)

Virtual care

prevention

Nicolas van de Kerkhof

Business Creation Manager
EIT Health (Germany)

Tom Van De putte

Co-founder, CEO
Bingli (Belgium)

Virtual care

prevention

Kristof Van Emelen

Obulytix (Belgium)

Drug discovery

Vanessa Vaughn

Project Manager
Ruhr Universitaet Bochum LAT (Germany)

Virtual care

Corinna Weber

SNAP DISCOVERY AG (Germany)

Virtual care

prevention

Martin Weihrauch

Smart In Media AG (Germany)

James Wilson

Vice President
Silverpeak (United Kingdom)

Drug discovery

Thomas Wollinger

CEO
Bochum Wirtschaftsentwicklung (Germany)

Armin Zlomuzica

The German Center for Mental Health (Germany)

Virtual care

Drug discovery

prevention